Netherlands· NL-17f47bb5603d

Pomalidomide Grindeks 3 mg harde capsules

A pomalidomide product containing pomalidomide, registered in Netherlands by Grindeks AS. The same ATC class is registered in 17 of our 19 countries.

ATC L04AX06

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about pomalidomideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Pomalidomide is registered in 17 of 19 countries.

Countries holding a registration under ATC L04AX06 (pomalidomide), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search pomalidomide products by name

Pomalidomide · ATC L04AX06

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pomalidomide costs, country by country.

Normalised to the WHO defined daily dose (3 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Pomalidomide · price per daily dose (3 mg)

USD · FX 28 Sept 2026

CH Switzerland$255.48

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: POMALIDOMIDE
Manufacturer: Grindeks AS
Country: Netherlands (NL)
ATC code: L04AX06
ATC class: Pomalidomide
Defined daily dose: 3 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
132093

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

277 interactions on record for pomalidomide.

Graded by severity as the source publishes them — 64 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check pomalidomide against other medicines How interaction checks work

Pomalidomide · interactions on record

277 records

64 severe
213 moderate

Most severe, free to view

ErythropoietinB03XA01severe
Darbepoetin alfaB03XA02severe
PeginesatideB03XA04severe
C1-inhibitor, plasma derivedB06AC01severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pomalidomide in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pomalidomide products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Pomalidomid +pharma, Pomalidomid Devatis
Belgium · Pomalidomide Eg, Pomalidomide Eugia
Bulgaria · Помалидомид Devatis, Помалидомид Булгермед
Cyprus · Pomalidomide, Pomalidomide Adalvo
Czechia · Pomalidomid Sanexcel, Pomalidomide Abdi
Germany · Pomadel, Pomalidomid 123 Acurae Pharma
Denmark · Pomalidomid Devatis, Pomalidomid Grindeks
Estonia · Pomalidomide Grindeks, Pomalidomide Olpha
Spain · Pomalidomida Abdi, Pomalidomida Erawya
Finland · Pomalidomid Avansor, Pomalidomid Devatis
France · Pomalidomide Eg, Pomalidomide Eugia
United Kingdom (Northern Ireland) · Pomalidomide, Pomalidomide Amarox
Greece · Polidma, Pomalidomide Anabiosis
Hungary · Pomalidomid Onkogen, Pomalidomide Grindeks
Ireland · Pomalidomide Clonmel, Pomalidomide Grindeks
Iceland · Imnovid, Pomalidomide Accord
Italy · Pomalidomide Abdi, Pomalidomide Aurobindo
Liechtenstein · Imnovid, Pomalidomide Accord
Lithuania · Pomalidomide Grindeks, Pomalidomide Olpha
Luxembourg · Pomalidomide Eg, Pomalidomide Eugia
Latvia · Pomalidomide Grindeks, Pomalidomide Olpha
Malta · Pomalidomide, Pomalidomide Clonmel
Norway · Imnovid, Pomalidomid Devatis
Poland · Pomalidomid Reig Jofre, Pomalidomide Eugia
Portugal · Pomalidomida Aurobindo, Pomalidomida Bluepharma
Romania · Pomalidomidă Dr. Reddy’s, Pomalidomidă Grindeks
Sweden · Davunfite, Pomalidomid Avansor
Slovenia · Pomadel, Pomalidomid Grindeks
Slovakia · Pomalidomid Grindeks, Pomalidomid Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/ce176cf0-30af-4f8f-8664-7aee5f9b31cf
GET /v1/drugs/ce176cf0-30af-4f8f-8664-7aee5f9b31cf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h132093_smpc.pdf",
  "strength": null,
  "atc_label": "Pomalidomide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg132093",
  "excipients": [
    "AZORUBINE (E 122)",
    "BRILJANTBLAUW FCF (E 133)",
    "BRILJANTZWART BN (E 151)",
    "CROSPOVIDON (E 1202)",
    "ERYTHROSINE (E 127)",
    "GELATINE (E 441)",
    "MALTODEXTRINE",
    "NATRIUMHYDROXIDE (E 524)",
    "NATRIUMSTEARYLFUMARAAT",
    "PATENTBLAUW V (E 131)",
    "POVIDON (E 1201)",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK (E 904)",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)",
    "TITAANDIOXIDE (E 171)",
    "WITTE INKT",
    "ZETMEEL, GEPREGELATINEERD"
  ],
  "substances": [
    "POMALIDOMIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h132093.pdf",
  "authorised_at": "2024/12/11",
  "procedure_number": "SE/H/2464/003",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "132093",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about pomalidomide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console